Nanologica AB (NICA) - Total Liabilities

Latest as of March 2026: Skr164.82 Million SEK ≈ $17.74 Million USD

Based on the latest financial reports, Nanologica AB (NICA) has total liabilities worth Skr164.82 Million SEK (≈ $17.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Nanologica AB - Total Liabilities Trend (2012–2025)

This chart illustrates how Nanologica AB's total liabilities have evolved over time, based on quarterly financial data. See Nanologica AB working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Nanologica AB Competitors by Total Liabilities

The table below lists competitors of Nanologica AB ranked by their total liabilities.

Company	Country	Total Liabilities
Desert Mountain Energy Corp V:DME	Canada	CA$3.23 Million
Pixelplus. Co. Ltd KQ:087600	Korea	₩21.54 Billion
Passat Société Anonyme PA:ALXIL	USA	€38.68 Million
ANGLER GAMING PLC EO -01 F:0QM	Germany	€4.17 Million
Greggs PLC LSE:GRG	UK	GBX773.20 Million
Vow Green Metals AS OL:VGM	Norway	Nkr248.38 Million
Catena Media plc ST:CTM	Sweden	Skr44.48 Million
HLscience Co. Ltd KQ:239610	Korea	₩2.15 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Nanologica AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Nanologica AB worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.15	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.69	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanologica AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanologica AB (2012–2025)

The table below shows the annual total liabilities of Nanologica AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr65.47 Million ≈ $7.05 Million	-5.10%
2024-12-31	Skr68.99 Million ≈ $7.42 Million	-13.03%
2023-12-31	Skr79.33 Million ≈ $8.54 Million	-2.49%
2022-12-31	Skr81.36 Million ≈ $8.76 Million	+74.13%
2021-12-31	Skr46.72 Million ≈ $5.03 Million	-12.48%
2020-12-31	Skr53.38 Million ≈ $5.74 Million	+39.87%
2019-12-31	Skr38.16 Million ≈ $4.11 Million	+259.34%
2018-12-31	Skr10.62 Million ≈ $1.14 Million	-55.70%
2017-12-31	Skr23.98 Million ≈ $2.58 Million	+143.71%
2016-12-31	Skr9.84 Million ≈ $1.06 Million	+14.02%
2015-12-31	Skr8.63 Million ≈ $928.58K	-24.54%
2014-12-31	Skr11.43 Million ≈ $1.23 Million	+252.85%
2013-12-31	Skr3.24 Million ≈ $348.74K	+20.11%
2012-12-31	Skr2.70 Million ≈ $290.36K	--

About Nanologica AB

ST:NICA Sweden Biotechnology

Market Cap

$20.24 Million

Skr188.06 Million SEK

Market Cap Rank

#25092 Global

#507 in Sweden

Share Price

Skr0.57

Change (1 day)

-1.38%

52-Week Range

Skr0.35 - Skr1.98

All Time High

Skr19.15